Effectiveness of TCC Followed by MBCT and Predictive Factors (Genetic, Clinical and Cognitive) Response
NCT ID: NCT02472483
Last Updated: 2019-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
158 participants
INTERVENTIONAL
2012-09-13
2019-09-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Impact of the Level of Mindfulness on the Management of Patients With Recurrent Depressive Disorders by the Mindfulness Based Cognitive Therapy ( MBCT ): an Exploratory Study
NCT02872324
Mindfulness Based Cognitive Therapy for Youth With Anxiety at Risk for Bipolar Disorder
NCT02090595
Comparing Cognitive-Behavioral Therapy Versus Mindfulness-Based Therapy for Autistic Adults
NCT06060860
Bounce-Back From Depression
NCT06832605
The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression Relapse
NCT01145872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bipolar disorder
Cognitive and Behavior Therapy (CBT) : 20-weeks CBT
\+ Mindfulness Based Cognitive Therapy (MBCT) : 8-weeks MBCT
Cognitive and Behavior Therapy (CBT)
20-weeks CBT
Mindfulness Based Cognitive Therapy (MBCT)
8-weeks MBCT
anxious disorders
Cognitive and Behavior Therapy (CBT) : 20-weeks CBT
\+ Mindfulness Based Cognitive Therapy (MBCT) : 8-weeks MBCT
Cognitive and Behavior Therapy (CBT)
20-weeks CBT
Mindfulness Based Cognitive Therapy (MBCT)
8-weeks MBCT
alcohol disorder
Cognitive and Behavior Therapy (CBT) : 20-weeks CBT
\+ Mindfulness Based Cognitive Therapy (MBCT) : 8-weeks MBCT
Cognitive and Behavior Therapy (CBT)
20-weeks CBT
Mindfulness Based Cognitive Therapy (MBCT)
8-weeks MBCT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive and Behavior Therapy (CBT)
20-weeks CBT
Mindfulness Based Cognitive Therapy (MBCT)
8-weeks MBCT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women
* Addressed to the CBT unit of the Clinique des Maladies Mentales et de l'Encéphale - CMME- (Sainte Anne Hospital)
* Having a bipolar I or II disorder (224 patients) or eating disorder (224 patients) : bulimia or discorder of use alcohol or gambling (224 patients)
* mood stabilizer treatment for more than six months, for bipolar patients
* Understanding and speaking French fluently
* Patient agreeing to participate and signing the consent form
Exclusion Criteria
* current manic, hypomanic, or depressive episode for bipolar patients
* Score on the Hamilton Depression Rating Scale - HDRS greater than or equal to 16
* Score on the Mania Rating Scale - MRS higher or equal to 6 for bipolar patients
* Schizophrenic disorder
* Severe somatic pathology (cancer, heart, kidney or respiratory failure, central neurological disorder), scalable, or are likely to be life-threatening in a period of less than one year
* Refusal of a mood stabilizer treatment for bipolar patients
* Inability to respond to assessment (eg failure or deterioration of mental ability.)
* No affiliation to a social security scheme
* Private topics of liberty by judicial or administrative decision
* Pregnant women
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier St Anne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip GORWOOD, MD., PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Sainte-Anne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Sainte Anne
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D470
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.